NVS, BMY pull European Zelmac filing

Novartis (NVS; SWX:NOVN) and Bristol-Myers (BMY) withdrew their European marketing application for Zelmac tegaserod to treat irritable bowel syndrome (IBS). NVS said the decision was based on a differ...